Unknown PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02300818

Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. (GME)

Magneto Therapy in the Therapy of Glaucoma

Sponsor: American Society Of Thermalism And Climatology Inc

Conditions Hypertension Ocular Primary Open Angle Glaucoma

Interventions Pulsed Electromagnetic Field Therapy Seawater eyedrops

Updated 7 times since 2017 Last updated: Jun 22, 2015 Started: Nov 30, 2014 Primary completion: Apr 30, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Hypertension Ocular and Primary Open Angle Glaucoma, this trial is ongoing. The trial is conducted by American Society Of Thermalism And Climatology Inc and has accumulated 7 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jul 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Jul 2017 [monthly]

Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE1_PHASE2

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Society Of Thermalism And Climatology Inc

Data source: American Society Of Thermalism And Climatology Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newark, United States